8 Indian cos in Fortune 500 list
New York: Eight Indian companies have made the cut in the list of world's 500 largest companies compiled by Fortune magazine, with Indian Oil and Reliance Industries finding a place in the top 100.
Out of the eight, five are state-run entities. With an annual revenue of USD 86,016 million, Indian Oil has cornered the 83rd spot up from 98th place last year.
Mukesh Ambani-led Reliance Industries is the first Indian private firm to made into the top 100 list. With an annual revenue of USD 76,119 million, RIL, has improved its ranking to 99 from previous year's 134.
Besides IOC and RIL, the other Indian companies in the list are steel-maker Tata Steel, auto company Tata Motors, oil entities Bharat Petroleum, Hindustan Petroleum and Oil & Natural Gas and public sector bank State Bank of India.
The list also features Citigroup, ArcelorMittal, led by people with Indian roots.
Fortune's global list of world's 500 largest companies for 2012, compiled on the basis of latest annual revenue figures, is topped by Royal Dutch Shell ending the retail major Wal-Mart Stores's two-year winning streak. The energy giant had annual revenues of USD 484,489 million.
At the second place is energy firm Exxon Mobil, followed by Wal-Mart Stores, energy company BP, and oil producer and refiner Sinopec Group.
Bharat Petroleum featured at 225th place, followed by Hindustan Petroleum (267), SBI (285), Tata Motors (314), ONGC (357) and Tata Steel (401).
According to magazine, Bharat Petroleum had the revenues to the tune of USD 44,582 million, followed by Hindustan Petroleum (USD 38,885 million), SBI (36,950 million), Tata Motors (USD 34,575 million), ONGC (30,746 million)and Tata Steel (USD 27,739 million.)
Interestingly, the 2011 list also featured the same eight Indian companies.
Last year, Bharat Petroleum was at the 272nd position, followed by SBI (292), Hindustan Petroleum (336), Tata Motors (359), ONGC (361) and Tata Steel (370).
8 Indian cos in Fortune 500 list
Direct tax collections rise 47% in Apr-Jun
Direct tax collections, net of refunds, increased 47.2 per cent to Rs 84,273 crore during April-June 2012-13, against Rs 57,267 crore in the corresponding period of last financial year.
The sharp rise was on account of higher refunds that pulled down the net collections in the year-ago period. Refunds in April-June this year stood at Rs 26,909 crore, compared with Rs 46,868 crore of tax refund in the corresponding period of 2011-12.
While gross collection of corporate taxes showed an increase of 3.48 per cent to Rs 70,594 crore, against Rs 68,223 crore in April-June last year, personal income tax mop-up was up by 13 per cent to Rs 40,520 crore, compared with Rs 35,858 crore in the same quarter of 2011-12.
Collections from wealth tax showed a dip of 3.03 per cent to Rs 32 crore, against Rs 33 crore in the same period last year.
Reflecting market conditions, collections from levy of securities transaction tax also showed a decline of 0.52 per cent to Rs 952 crore, compared with Rs 957 crore in the year ago period, the Central Board of Direct Taxes said in a press statement issued on Monday.
At Rs 84,273 crore, net direct tax collections are less than 15 per cent of this year’s Budget estimate of Rs 5.7 lakh crore. The target represents an increase of about 25 per cent over the last year’s actual collections.
Refunds to the tune of Rs 98,000 crore in 2011-12 pulled down the direct tax collections during the year to Rs 4.9 lakh crore, against the Budget Estimate of Rs 5.3 lakh crore.
Direct tax collections rise 47% in Apr-Jun
Govt considering Rs 2,000-cr VC fund for pharma sector
Press Trust Of India / Jul 04, 2012, 00:47 IST
The government on Tuesday said it was considering forming a venture capital fund of Rs 2,000 crore to promote research and development in the pharmaceutical sector.
“We are talking with Export Import Bank for this," Commerce Minister Anand Sharma told reporters in New Delhi.
Sharma was reviewing the pharma sector with industry representatives and government secretaries.
In the meeting, the pharma industry representatives raised issues like problems in getting approvals from the health ministry.
Sharma said all the concerns of the industry will be discussed by a committee of secretaries.
Govt considering Rs 2,000-cr VC fund for pharma sector